Showing 861 - 880 results of 100,410 for search '(( 5 non decrease ) OR ( 5 ((step decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.51s Refine Results
  1. 861
  2. 862
  3. 863
  4. 864
  5. 865
  6. 866

    Table_5_The non-canonical inflammasome activators Caspase-4 and Caspase-5 are differentially regulated during immunosuppression-associated organ damage.docx by Mohamed Ghait (17523321)

    Published 2023
    “…<p>The non-canonical inflammasome, which includes caspase-11 in mice and caspase-4 and caspase-5 in humans, is upregulated during inflammatory processes and activated in response to bacterial infections to carry out pyroptosis. …”
  7. 867
  8. 868
  9. 869

    Changes to chromatin state with PRMT5 inhibition. by Shelby L. Sloan (10803222)

    Published 2021
    “…At a FDR of 10%, more genomic sites show decreased accessibility than increased. …”
  10. 870
  11. 871

    Global Land Use Change Impacts on Soil Nitrogen Availability and Environmental Losses by Jing Wang (6206297)

    Published 2025
    “…However, how global land use changes impact soil N supply and potential N loss remains elusive. By compiling a global data set of 1,782 paired observations from 185 publications, we show that land use conversion from natural to managed ecosystems significantly reduced NNM by 7.5% (−11.5, −2.8%) and increased NN by 150% (86, 194%), indicating decreasing N availability while increasing potential N loss through denitrification and nitrate leaching. …”
  12. 872

    Time course of best-corrected visual acuity (BCVA) in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

    Published 2025
    “…In the non-recurrence group, CRT improved from 482.5 ± 112.8 to 294.7 ± 65.3, 302.0 ± 68.0, 284.7 ± 55.4, 285.3 ± 70.2, 265.2 ± 65.0, and 266.1 ± 78.2 μm at 1, 3, 6, 12, 24, and 36 months, respectively (Kruskal-Wallis test, p < 0.001; <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0332941#pone.0332941.g006" target="_blank">Fig 6</a>).…”
  13. 873
  14. 874
  15. 875

    Sensitivity of the optimal pathway to increased and decreased discounting (5% and 0%), to the addition of other non-cardiovascular health care costs in added years of life, the measurement of health gain in QALYs rather than DALYs, and to a reduction in the cost of statin drugs to the much lower price in New Zealand (NB. the order of interventions is altered only by the reduction in statin price, with statins becoming a more cost-effective intervention option than the blood pressure-lowering drugs). by Linda J. Cobiac (149055)

    Published 2012
    “…<p>Sensitivity of the optimal pathway to increased and decreased discounting (5% and 0%), to the addition of other non-cardiovascular health care costs in added years of life, the measurement of health gain in QALYs rather than DALYs, and to a reduction in the cost of statin drugs to the much lower price in New Zealand (NB. the order of interventions is altered only by the reduction in statin price, with statins becoming a more cost-effective intervention option than the blood pressure-lowering drugs).…”
  16. 876
  17. 877
  18. 878

    Decrease of SMAD3 protein, but not SMAD2 in DBA iPSCs. by Jingping Ge (636557)

    Published 2015
    “…The nuclear p-SMAD2 decreased in <i>RPL5</i> mutant and corrected lines. …”
  19. 879

    Figure S1 - The RNA Degradation Pathway Regulates the Function of GAS5 a Non-Coding RNA in Mammalian Cells by Hidenori Tani (169942)

    Published 2013
    “…<p><b>Knockdown of UPF1 increases the expression level of GAS5, and decreases the glucocorticoid-responsive genes.…”
  20. 880

    Selectivity of PRMT5 inhibition with C220. by Shelby L. Sloan (10803222)

    Published 2021
    “…For all cell lines, effects of PRMT5 inhibition with C220 treatment on biomarkers of PRMT5 activity shows a dose-dependent decrease in global marks of symmetric di-methylarginine (SDMA) and symmetric di-methylation of histone H4 arginine-3 (H4R3me2s) with a minimal effect to PRMT5 or global asymmetric di-methylarginine (ADMA). …”